Cuban Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma)With more than 100 innovative projects, the Cuban Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma) continues developing new medicines, despite the U.S. blockade against Cuba.

The European Union urged the United States to stop the blockadeThe European Union (EU) warned that the blockade imposed by the United States on Cuba hurts its interests and reiterated its rejection of the extraterritoriality of that policy.

Soberana 02 anti-COVID-19 vaccine candidateResults from the trial of Cuba anti-COVID-19 vaccine candidate Soberana 02 are out. Its two-dose immunization scheme, after its Phase III trial, has achieved 62 percent efficacy, the manufacturer BioCubaFarma announced Saturday.